Clinical Trial Update: Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for KXV01 TCR Lentinvivo injection in advanced solid tumors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KXV01 TCR Lentinvivo

Snippet

Sponsor: TCRx Therapeutics Co.Ltd | Conditions: Advanced Solid Cancer | Phase 1 | Status: NOT_YET_RECRUITING